Mirum Pharmaceuticals Ownership | Who Owns Mirum Pharmaceuticals?
Mirum Pharmaceuticals Ownership Summary
Mirum Pharmaceuticals is owned by 91.37% institutional investors, 2.78% insiders, and 5.85% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 13.84% of MIRM shares. Eventide Gilead N is the top mutual fund, with 2.92% of its assets in Mirum Pharmaceuticals shares.
MIRM Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Mirum Pharmaceuticals | 91.37% | 2.78% | 5.85% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Frazier life sciences management | 6.50M | 13.84% | $222.08M |
Janus henderson group | 4.58M | 9.59% | $189.48M |
Blackrock funding, inc. /de | 3.43M | 7.19% | $142.02M |
Blackrock | 3.24M | 6.90% | $110.71M |
Bvf inc/il | 2.80M | 5.85% | $115.64M |
Eventide asset management | 2.61M | 5.46% | $107.80M |
Vanguard group | 2.42M | 5.07% | $100.26M |
State street | 1.50M | 3.19% | $51.16M |
Novo | 1.50M | 3.14% | $62.02M |
Rock springs capital management lp | 1.47M | 3.08% | $60.85M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Frazier life sciences management | 6.50M | 10.39% | $222.08M |
Boone capital management | 581.84K | 8.12% | $24.06M |
Nan fung group | 125.33K | 4.43% | $5.18M |
Bvf inc/il | 2.80M | 3.92% | $115.64M |
Novo | 1.50M | 3.76% | $62.02M |
First turn management | 506.91K | 3.75% | $20.96M |
Bioimpact capital | 589.58K | 3.46% | $24.38M |
Tang capital management | 1.24M | 3.38% | $51.15M |
Prosight management, lp | 314.80K | 3.22% | $10.76M |
Highlander partners | 122.98K | 2.89% | $5.09M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 3.24M | 0.00% | 785.78K |
Jpmorgan chase | 385.14K | 0.00% | 357.38K |
Bnp paribas arbitrage, snc | 261.64K | 0.01% | 261.64K |
Raymond james financial | 256.61K | 0.00% | 256.61K |
Nuveen asset management | 722.15K | 0.01% | 229.75K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
State street | 1.50M | 0.00% | -1.33M |
Eventide asset management | 2.61M | 1.96% | -838.42K |
William blair investment management | - | - | -677.94K |
Cadian capital management, lp | - | - | -475.71K |
Checkpoint capital | - | - | -362.19K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Bnp paribas arbitrage, snc | 261.64K | 0.01% | 261.64K | $10.82M |
Raymond james financial | 256.61K | 0.00% | 256.61K | $10.61M |
D. e. shaw | 157.35K | 0.00% | 157.35K | $6.51M |
Algert global | 68.29K | 0.07% | 68.29K | $2.82M |
Canada pension plan investment board | 41.80K | 0.00% | 41.80K | $1.73M |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -5.00 |
Cibc private wealth group | -10.00 |
Capital performance advisors llp | -16.00 |
Bessemer group | -30.00 |
Private wealth management group | -35.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 194 | 5.43% | 43,660,980 | -17.71% | 91 | 0.74% | 109 | -3.54% | 56 | 40.00% |
Sep 30, 2024 | 184 | 11.52% | 53,056,700 | -0.10% | 111 | 0.87% | 114 | 25.27% | 40 | -20.00% |
Jun 30, 2024 | 165 | -5.17% | 53,108,448 | -0.23% | 113 | 0.88% | 91 | -3.19% | 50 | -3.85% |
Mar 31, 2024 | 174 | -8.42% | 53,228,863 | 6.43% | 113 | 0.99% | 94 | -18.97% | 52 | 1.96% |
Dec 31, 2023 | 190 | 19.50% | 50,012,606 | 2.71% | 107 | 0.76% | 116 | 18.37% | 51 | 59.38% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Eventide Gilead N | 1.43M | 2.92% | -341.18K |
Vanguard US Total Market Shares ETF | 1.41M | 2.87% | 1.77K |
Vanguard Total Stock Mkt Idx Inv | 1.31M | 2.67% | 1.21K |
Eventide Healthcare & Life Sciences I | 1.17M | 2.38% | -498.97K |
iShares Russell 2000 ETF | 1.04M | 2.13% | -9.02K |
Polar Capital Biotech S Inc | 1.00M | 2.04% | - |
US Small-Cap Growth II Equity Comp | 767.71K | 1.60% | -660.00 |
Janus Henderson Global Life Sciences | 762.42K | 1.59% | -63.30K |
MEDICAL BioHealth EUR Acc | 756.50K | 1.59% | - |
T. Rowe Price New Horizons | 767.49K | 1.57% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 18, 2025 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | $107.34K |
Mar 17, 2025 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | $80.11K |
Mar 17, 2025 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | $2.22M |
Mar 17, 2025 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | $124.80K |
Mar 17, 2025 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | $128.22K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | 10 | 21 |
2024 Q4 | - | 1 |
2024 Q3 | 2 | 1 |
2024 Q2 | - | 2 |
2024 Q1 | 2 | 11 |
MIRM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools